PT  - JOURNAL ARTICLE
AU  - Chen, Jin
TI  - HIF1α or HIF2α: Enhancing CD8<sup>+</sup> T-cell Fitness for Antitumor Immunity
AID  - 10.1158/2326-6066.CIR-21-0114
DP  - 2021 Apr 01
TA  - Cancer Immunology Research
PG  - 364--364
VI  - 9
IP  - 4
4099  - http://cancerimmunolres.aacrjournals.org/content/9/4/364.short
4100  - http://cancerimmunolres.aacrjournals.org/content/9/4/364.full
SO  - Cancer Immunol Res2021 Apr 01; 9
AB  - Adoptive T-cell therapy requires the transferred lymphocytes to adapt to the hypoxic tumor microenvironment. In this issue, Veliça and colleagues found that modified HIF2α expression in CD8+ T cells increases antitumor efficacy.See article by Veliça et al., p. 401